Prolargin and matrix metalloproteinase ‐2 in heart failure after heart transplantation and their association with haemodynamics
ConclusionsThe normalization pattern in HF patients of plasma prolargin and MMP ‐2 post‐HT towards controls' levels and their associations with improved haemodynamics indicate that prolargin and MMP‐2 may reflect, in part, the aberrant ECM remodelling involved in the pathophysiology of HF and associated PH. Their potential clinical use as biomarkers or targets for future therapy in HF and related PH remains to be investigated.
Source: ESC Heart Failure - Category: Cardiology Authors: Abdulla Ahmed,
Salaheldin Ahmed,
Mattias Arvidsson,
Habib Bouzina,
Jakob Lundgren,
G öran Rådegran Tags: Original Research Article Source Type: research
More News: Brain | Cardiology | Heart | Heart Failure | Heart Transplant | Hypertension | Neurology | Pulmonary Hypertension | Stroke | Transplants